179011-37-1

Basic information

• Product Name: Benzoic acid, 2,4-difluoro-5-nitro-, ethyl ester
• CAS NO: 179011-37-1
• Molecular Formula: C9H7F2NO4
• Molecular Weight: 231.156
• Mol File: 179011-37-1.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2,4-difluoro-5-nitro-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2,4-difluoro-5-nitro-, ethyl ester(179011-37-1)
• EPA Substance Registry System: Benzoic acid, 2,4-difluoro-5-nitro-, ethyl ester(179011-37-1)

Safety Data

• Hazardous Substances Data: 179011-37-1(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 153775-33-8 2,4-difluoro-5-nitro-benzoic acid 
• 1583-58-0 2,4-difluoro-benzoic acid 
• 108928-00-3 ethyl 2,4-di-fluorobenzoate 

Downstream Products

• 106125-55-7 methyl 4-amino-2-hydroxy-5-nitrobenzoate 
• 1374298-19-7 methyl 4, 5-diamino-2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxylate 
• 89722-54-3 methyl 4-(benzylamino)-2-methoxy-5-nitrobenzoate 
• 1374298-16-4 methyl 4-amino-2-((2-methylallyl)oxy)-5-nitrobenzoate 
• 1374298-17-5 methyl 4-amino-2-hydroxy-3-(2-methylprop-2-en-1-yl)-5-nitrobenzoate 
• 1374298-76-6 methyl 2-(2-chloro-6-fluorobenzamido)-7,7-dimethyl-7,8-dihydro-1H-benzofuro[4,5-d]imidazole-5-carboxylate 
• 1374298-79-9 7-[(2,6-dichlorophenyl)amino]-2-methyl-8H-imidazo[4,5-e][1,3]benzoxazole-4-carboxylic acid 
• 1374298-80-2 methyl 4,5-diamino-2-hydroxybenzoate 
• 1374298-81-3 methyl 2-[(2,6-dichlorophenyl)amino]-6-hydroxy-1H-benzimidazole-5-carboxylate 
• 1374298-82-4 methyl 2-[(2,6-dichlorophenyl)amino]-6-hydroxy-7-nitro-1H-benzimidazole-5-carboxylate 
• 1374298-83-5 methyl 7-[(2,6-dichlorophenyl)amino]-2-methyl-8H-imidazo[4,5-e][1,3]benzoxazole-4-carboxylate 
• 1374298-88-0 methyl 7-amino-2-[(2,6-dichlorophenyl)amino]-6-hydroxy-1H-benzimidazole-5-carboxylate 
• 1374298-89-1 methyl 2-cyclopropyl-7-[(2,6-dichlorophenyl)amino]-8H-imidazo[4,5-e][1,3]benzoxazole-4-carboxylate 
• 1374295-92-7 N-Cyclohexyl-2-[(3,5-dichloropyridin-4-yl)amino]-7,7-dimethyl-7,8-dihydro-1H-furo[3,2-e]benzimidazole-5-carboxamide 

Relevant articles and documents

Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models

Ferrostatin-1 (Fer-1) inhibits ferroptosis, a form of regulated, oxidative, nonapoptotic cell death. We found that Fer-1 inhibited cell death in cellular models of Huntington's disease (HD), periventricular leukomalacia (PVL), and kidney dysfunction; Fer-1 inhibited lipid peroxidation, but not mitochondrial reactive oxygen species formation or lysosomal membrane permeability. We developed a mechanistic model to explain the activity of Fer-1, which guided the development of ferrostatins with improved properties. These studies suggest numerous therapeutic uses for ferrostatins, and that lipid peroxidation mediates diverse disease phenotypes.

Tricyclic Compounds As mPGES-1 Inhibitors

The present invention relates to tricyclic compounds of formula (I) or pharmaceutically acceptable salt thereof as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.

3H-IMIDAZO [4, 5 -C] PYRIDINE- 6 -CARBOXAMIDES AS ANTI- INFLAMMATORY AGENTS

The present invention relates to compounds of general formula (I) in which A, L, M, Q2, Q3, Q4, R1, R5, Ra, Rb, Rc, W, X, Y, Z1, Z2, Z3 are defined in the description, the salts thereof, particularly the physiologically acceptable salts thereof. The compounds are of potential utility in the treatment and/or prevention of inflammatory diseases and associated conditions, in particular, in the treatment and/or prevention of pain. The invention also relates to the use of such compounds as medicaments, to pharmaceutical compositions containing them, and to their preparation.